Widely used:Recently Viewed
Clear AllQuality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$47,147 Mln
P/E Ratio
46.5
P/B Ratio
2.19
Industry P/E
--
Debt to Equity
0.24
ROE
0.05 %
ROCE
3.88 %
Div. Yield
0.34 %
Book Value
43.32
EPS
2.05
CFO
$10,707.33 Mln
EBITDA
$13,991.95 Mln
Net Profit
$653.27 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Alcon (ALC)
| 13.58 | 0.68 | 5.65 | 22.41 | 9.67 | 12.71 | -- |
|
BSE Sensex
| 2.61 | 3.71 | 5.78 | 8.89 | 11.76 | 20.11 | 11.35 |
|
S&P Midcap 400
| -8.37 | -2.02 | -11.96 | -1.34 | 3.58 | 11.87 | 6.46 |
|
2023
|
2022
|
2021
|
2020
|
|
|---|---|---|---|---|
|
Alcon (ALC)
| 13.96 | -20.87 | 32.42 | 16.63 |
|
S&P Midcap 400
| 14.45 | -14.48 | 23.21 | 11.81 |
|
BSE Sensex
| 18.74 | 4.44 | 21.99 | 15.75 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs),... and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland. Address: Chemin de Blandonnet 8, Geneva, Switzerland, 1214 Read more
Executive Chairman
Mr. F. Michael Ball
CEO & Director
Mr. David J. Endicott
Headquarters
Geneva
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Alcon Inc (ALC) stood at $ 30,347 Mln as on 31-Dec-24
The share price of Alcon Inc (ALC) is $96.42 (NYSE) as of 29-Apr-2025 16:10 EDT. Alcon Inc (ALC) has given a return of 9.67% in the last 3 years.
Alcon Inc (ALC) has a market capitalisation of $ 47,147 Mln as on 29-Apr-2025. As per Value Research classification, it is a Mid Cap company.
The P/E ratio of Alcon Inc (ALC) is 46.50 times as on 29-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Alcon Inc (ALC) and enter the required number of quantities and click on buy to purchase the shares of Alcon Inc (ALC).
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland. Address: Chemin de Blandonnet 8, Geneva, Switzerland, 1214
The CEO & director of Mr. F. Michael Ball. is Alcon Inc (ALC), and CFO & Sr. VP is Mr. David J. Endicott.
There is no promoter pledging in Alcon Inc (ALC).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|
| Alcon Inc. (ALC) | Ratios |
|---|---|
|
Return on equity(%)
|
4.83
|
|
Operating margin(%)
|
14.61
|
|
Net Margin(%)
|
10.27
|
|
Dividend yield(%)
|
--
|
Yes, TTM profit after tax of Alcon Inc (ALC) was $1,018 Mln.
$1.10
(
